Medicare Spending Up for Decedents Versus Survivors

Share this content:
Medicare Spending Up for Decedents Versus Survivors
Medicare Spending Up for Decedents Versus Survivors

WEDNESDAY, July 20, 2016 (HealthDay News) -- Medicare per capita spending was much higher for beneficiaries who died during 2014 than for those who survived the entire year, according to a report published by the Kaiser Family Foundation.

Juliette Cubanski, Ph.D., M.P.H., from the Kaiser Family Foundation, and colleagues examined Medicare per capita spending in 2014 and trends since 2000 for beneficiaries in traditional Medicare who died at some point during 2014 compared with those who survived the entire year.

The researchers found that 55 percent of the Medicare beneficiaries who died at some point in 2014 were age 80 years or older. The average per capita spending for traditional Medicare beneficiaries who died was $34,529 per year, which was almost four-fold higher than the per capita spending for survivors ($9,121). The average Medicare spending among decedents was 80 percent higher per person in 2014 versus 2000; for survivors, the average spending more than doubled from 2000 to 2014. Among decedents in traditional Medicare in 2014, inpatient hospital services accounted for the largest amount of per capita Medicare spending. Medicare per capita spending was higher for decedents who were younger than 65 years ($41,950) than for those older than 65 years ($33,676).

"Our analysis shows that Medicare per capita spending for beneficiaries in traditional Medicare who died at some point in 2014 was substantially higher than for those who lived the entire year, as might be expected," the authors write.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »